Protein Signature May Predict Who Responds to Hepatitis C Treatment

Friday, October 31, 2008 - 13:35 in Health & Medicine

(PhysOrg.com) -- A tell-tale set of newly-identified proteins may be able to predict who will most likely respond to standard therapy for hepatitis C infection, say researchers in the Duke Clinical Research Institute (DCRI). It is a development that could help patients facing one of the most taxing therapeutic regimens in medicine.

Read the whole article on Physorg

More from Physorg

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net